Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Board Meeting Scheduled On Thursday, 18 June 2026 Cancelled
Sudarshan Pharma Industries cancelled its board meeting scheduled for June 18, 2026. The meeting was called off due to unavoidable reasons, as per the intimation dated June 15, 2026.
Jun 18 2026 15:30:16
Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 18Th June, 2026
Sudarshan Pharma's Board of Directors will convene on June 18, 2026, to evaluate and potentially approve a proposal for raising capital. The fundraise may involve issuing equity shares, convertible securities, or debt instruments through methods like Private Placement or QIP.
Jun 15 2026 19:21:06
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment
Sudarshan Pharma Industries has allotted 90,00,000 equity shares to its promoters at an issue price of Rs.16.983 each, following the conversion of previously issued warrants. This transaction increased the promoter and promoter group shareholding to 58.93% of the company's paid-up capital.
Jun 12 2026 20:01:27
Sudarshan Pharma Industries Ltd - 543828 - Meeting Of Warrants Committee Of The Company Scheduled On Thursday, 11/June/2026 Now Postponed To Friday, 12/June/2026
Sudarshan Pharma Industries' Warrants Committee meeting, originally scheduled for June 11, 2026, has been postponed to June 12, 2026. The meeting will consider and approve the conversion of warrants and the allotment of equity shares.
Jun 11 2026 17:43:02
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Sudarshan Pharma Industries Ltd has incorporated Sudarshan Industries Inc. as a wholly-owned subsidiary in Delaware, USA, on June 5, 2026. This move aims to enlarge the company's customer base in the United States for pharmaceutical and allied goods.
Jun 10 2026 15:58:41
Sudarshan Pharma Industries Ltd - 543828 - Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026
Sudarshan Pharma Industries' Warrants Committee is scheduled to meet on June 11, 2026. The meeting will focus on considering and approving the conversion of warrants into equity shares and their subsequent allotment, which could impact the company's share capital.
Jun 08 2026 19:49:46
Sudarshan Pharma Industries Ltd - 543828 - Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Sudarshan Pharma Industries' promoter, Hemal Vasantrai Mehta, released a pledge on 20 lakh shares, which represents 0.83% of the total share capital. This action reduced the total encumbered holding to 25.77%, indicating a deleveraging by the promoter.
Jun 05 2026 21:12:29
Sudarshan Pharma Industries Ltd - 543828 - Reply To The Email Dated 18Th May 2026 Seeking 'Discrepancies In Financial Results'
Sudarshan Pharma reported strong consolidated annual results for FY26, with revenue increasing 39.21% to Rs. 703.06 cr and net profit rising 55.64% to Rs. 23.30 cr. The company also acquired an API manufacturing facility for Rs. 25.50 cr.
Jun 04 2026 18:09:00
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sudarshan Pharma Industries published a postal ballot notice for shareholder approval. Key resolutions include migrating from BSE SME to the Main Board, listing on NSE, and appointing two new directors. This move aims to enhance market visibility and corporate governance.
May 26 2026 10:32:00
Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Sudarshan Pharma conducts postal ballot for a strategic move to migrate equity shares from the BSE SME Platform to BSE Main Board and NSE Main Board. This aims to boost market recognition and investor participation. Shareholders will also vote on two director appointments.
May 25 2026 14:40:23
Read More